aspartic acid has been researched along with oxidopamine in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (9.52) | 18.7374 |
| 1990's | 6 (28.57) | 18.2507 |
| 2000's | 7 (33.33) | 29.6817 |
| 2010's | 5 (23.81) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Boulu, RG; Buisson, A; Callebert, J; Mathieu, E; Plotkine, M | 1 |
| Di Chiara, G; Morelli, M | 1 |
| Chapman, AG; Dürmuller, N; Lees, GJ; Meldrum, BS | 1 |
| Beart, PM; Christie, MJ; Gibson, SJ; Louis, WJ; Papasava, M; Singer, G | 1 |
| Brodin, E; Goiny, M; Herrera-Marschitz, M; Hökfelt, T; Meana, JJ; Morino, P; Silveira, R; Ungerstedt, U; You, ZB | 1 |
| Godukhin, O; Goiny, M; Herrera-Marschitz, M; Hökfelt, T; Kehr, J; Nylander, I; Pettersson, E; Shou, HZ; Terenius, L; Ungerstedt, U; You, ZB | 1 |
| Biggs, CS; Fowler, LJ; Starr, MS; Whitton, PS | 1 |
| Abarca, J; Bustos, G | 1 |
| Berger, SP; Fox, L; Ho, LB; Reid, MS | 1 |
| Badiani, A; Browman, KE; Fraioli, S; Oates, MM; Ostrander, MM; Robinson, TE; Wolf, ME; Xue, CJ | 1 |
| Araki, T; Imai, Y; Itoyama, Y; Kato, H; Mizugaki, M; Tanji, H | 1 |
| Bianchi, L; Bolam, JP; Della Corte, L; Galeffi, F | 1 |
| Alonso, TJ; Castro Fuentes, R; García Dopico, J; González Hernández, T; Perdomo Díaz, J; Rodríguez Díaz, M | 1 |
| Mignon, LJ; Wolf, WA | 1 |
| Abarca, J; Bustos, G; Bustos, V; Campusano, J; Moya, C; Noriega, V; Riquelme, E | 1 |
| Goursaud, S; Hermans, E; Massie, A; Meshul, CK; Michotte, Y; Schallier, A; Vermoesen, K | 1 |
| Chen, D; Fu, W; Sun, X; Wang, X; Zheng, Z; Zhuang, W | 1 |
| Fernández, M; Martín, ED; Oliva, I | 1 |
| Fang, F; Fang, K; Hou, Z; Lei, H; Lin, X; Liu, M; Liu, S; Meng, H; Sun, B; Zhang, Z | 1 |
| Asensio, MJ; García-Sanz, P; Herranz, AS; Moratalla, R; Solís, O | 1 |
| Annunziato, L; Della Notte, S; Scorziello, A; Secondo, A; Sisalli, MJ; Ventra, C | 1 |
21 other study(ies) available for aspartic acid and oxidopamine
| Article | Year |
|---|---|
Striatal protection induced by lesioning the substantia nigra of rats subjected to focal ischemia.
Topics: Animals; Aspartic Acid; Brain Ischemia; Cerebral Infarction; Corpus Striatum; Dopamine; Extracellular Space; Glutamates; Glutamic Acid; Male; Oxidopamine; Rats; Rats, Inbred Strains; Substantia Nigra | 1992 |
Stereospecific blockade of N-methyl-D-aspartate transmission by MK 801 prevents priming of SKF 38393-induced turning.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Aspartic Acid; Dibenzocycloheptenes; Dizocilpine Maleate; Hydroxydopamines; Male; N-Methylaspartate; Oxidopamine; Rats; Rats, Inbred Strains; Stereoisomerism; Stereotyped Behavior; Sympathectomy, Chemical; Synaptic Transmission | 1990 |
Excitotoxicity of NMDA and kainic acid is modulated by nigrostriatal dopaminergic fibres.
Topics: Animals; Aspartic Acid; Choline O-Acetyltransferase; Corpus Striatum; Dopamine; Glutamate Decarboxylase; Hydroxydopamines; Kainic Acid; N-Methylaspartate; Oxidopamine; Rats; Rats, Inbred Strains; Substantia Nigra | 1989 |
6-Hydroxydopamine and excitotoxin lesions of medial prefrontal cortex fail to affect schedule-induced drinking in the rat.
Topics: Animals; Aspartic Acid; Brain Mapping; Dopamine; Drinking Behavior; Food Deprivation; Frontal Lobe; Hydroxydopamines; Male; N-Methylaspartate; Neural Pathways; Nucleus Accumbens; Oxidopamine; Rats; Reinforcement Schedule; Tegmentum Mesencephali | 1986 |
On the origin of striatal cholecystokinin release: studies with in vivo microdialysis.
Topics: 3,4-Dihydroxyphenylacetic Acid; Afferent Pathways; Animals; Aspartic Acid; Calcium; Cholecystokinin; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Glutamates; Glutamic Acid; Homovanillic Acid; Male; Microdialysis; Oxidopamine; Potassium; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Sincalide | 1994 |
Modulation of neurotransmitter release by cholecystokinin in the neostriatum and substantia nigra of the rat: regional and receptor specificity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Aspartic Acid; Cholecystokinin; Dopamine; Dynorphins; Endorphins; gamma-Aminobutyric Acid; Glutamic Acid; Homovanillic Acid; Kinetics; Male; Neostriatum; Neurons; Neurotransmitter Agents; Organ Specificity; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Substantia Nigra; Time Factors | 1996 |
Extracellular levels of glutamate and aspartate in the entopeduncular nucleus of the rat determined by microdialysis: regulation by striatal dopamine D2 receptors via the indirect striatal output pathway?
Topics: Animals; Aspartic Acid; Corpus Striatum; Dopamine Agonists; Dopamine Antagonists; Glutamic Acid; Hypothalamus; Male; Microdialysis; Neural Pathways; Oxidopamine; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Reserpine; Veratridine | 1997 |
Differential regulation of glutamate, aspartate and gamma-amino-butyrate release by N-methyl-D-aspartate receptors in rat striatum after partial and extensive lesions to the nigro-striatal dopamine pathway.
Topics: Animals; Aspartic Acid; Corpus Striatum; Dizocilpine Maleate; Dopamine; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid; Glutamic Acid; Homeostasis; Kinetics; Male; Microdialysis; Oxidopamine; Prosencephalon; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Substantia Nigra | 1999 |
Nicotine stimulation of extracellular glutamate levels in the nucleus accumbens: neuropharmacological characterization.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amino Acid Transport System X-AG; Animals; Aspartic Acid; ATP-Binding Cassette Transporters; Biological Transport; Denervation; Dicarboxylic Acids; Dopamine; Extracellular Space; Glutamic Acid; Haloperidol; Kainic Acid; Kinetics; Male; Mecamylamine; Microdialysis; Neurotransmitter Uptake Inhibitors; Nicotine; Nucleus Accumbens; Oxidopamine; Pyrrolidines; Rats; Rats, Sprague-Dawley | 2000 |
Environmental modulation of the response to amphetamine: dissociation between changes in behavior and changes in dopamine and glutamate overflow in the rat striatal complex.
Topics: Amphetamine; Animals; Apomorphine; Aspartic Acid; Behavior, Animal; Central Nervous System Stimulants; Dopamine; Dopamine Agonists; Dopamine Uptake Inhibitors; Environment; Glutamic Acid; Male; Microdialysis; Neostriatum; Oxidopamine; Rats; Rats, Sprague-Dawley; Sympathectomy, Chemical; Sympatholytics | 2000 |
Temporal changes of dopaminergic and glutamatergic receptors in 6-hydroxydopamine-treated rat brain.
Topics: Animals; Aspartic Acid; Autoradiography; Brain; Dopamine; Functional Laterality; Male; Medial Forebrain Bundle; Oxidopamine; Radioligand Assay; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Glutamate; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate; Time Factors | 2000 |
The effect of 6-hydroxydopamine lesions on the release of amino acids in the direct and indirect pathways of the basal ganglia: a dual microdialysis probe analysis.
Topics: Adrenergic Agents; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Aspartic Acid; Basal Ganglia; Chromatography, High Pressure Liquid; Excitatory Amino Acid Agonists; gamma-Aminobutyric Acid; Glutamic Acid; Immunohistochemistry; Injections, Intraventricular; Kainic Acid; Male; Microdialysis; Models, Animal; Oxidopamine; Parkinson Disease; Potassium; Rats; Rats, Wistar; Tyrosine 3-Monooxygenase | 2003 |
Extracellular taurine in the substantia nigra: taurine-glutamate interaction.
Topics: Adrenergic Agents; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Aspartic Acid; Brain Chemistry; Calcium; Chelating Agents; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Interactions; Egtazic Acid; Excitatory Amino Acid Antagonists; Extracellular Space; gamma-Aminobutyric Acid; Glutamic Acid; Kainic Acid; Ketamine; Male; Membrane Potentials; Microdialysis; N-Methylaspartate; Oxidopamine; Potassium; Rats; Rats, Sprague-Dawley; Substantia Nigra; Taurine; Time Factors; Zinc | 2004 |
8-hydroxy-2-(di-n-propylamino)tetralin reduces striatal glutamate in an animal model of Parkinson's disease.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Aspartic Acid; Corpus Striatum; Denervation; Disease Models, Animal; Glutamic Acid; Injections, Subcutaneous; Male; Microdialysis; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Receptor Agonists; Sympatholytics | 2005 |
NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease.
Topics: Analysis of Variance; Animals; Aspartic Acid; Brain-Derived Neurotrophic Factor; Cell Count; Disease Models, Animal; Dizocilpine Maleate; Dopamine; Excitatory Amino Acid Antagonists; Functional Laterality; Glutamic Acid; Male; Microdialysis; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; RNA, Messenger; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase; Up-Regulation | 2009 |
Time-dependent changes in GLT-1 functioning in striatum of hemi-Parkinson rats.
Topics: Animals; Aspartic Acid; Blotting, Western; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Excitatory Amino Acid Transporter 1; Excitatory Amino Acid Transporter 2; Immunohistochemistry; Medial Forebrain Bundle; Oxidopamine; Parkinson Disease, Secondary; Piperazines; Rats; Synaptosomes; Time Factors | 2010 |
Neural metabolite changes in corpus striatum after rat multipotent mesenchymal stem cells transplanted in hemiparkinsonian rats by magnetic resonance spectroscopy.
Topics: Animals; Aspartic Acid; Cell Differentiation; Cell Survival; Choline; Corpus Striatum; Creatine; Disease Models, Animal; Female; Magnetic Resonance Spectroscopy; Male; Mesenchymal Stem Cell Transplantation; Microtubule-Associated Proteins; Neurons; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Time Factors; Tyrosine 3-Monooxygenase | 2013 |
Dopamine release regulation by astrocytes during cerebral ischemia.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Aspartic Acid; Astrocytes; Calcium; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Drug Interactions; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Exocytosis; Functional Laterality; Hypoxia-Ischemia, Brain; In Vitro Techniques; Mice; Mice, Inbred C57BL; Neurotoxicity Syndromes; Oxidopamine; Piperazines; Tetrodotoxin; Time Factors | 2013 |
Parkinson's disease: in vivo metabolic changes in the frontal and parietal cortices in 6-OHDA treated rats during different periods.
Topics: Animals; Aspartic Acid; Choline; Corpus Striatum; Creatine; Disease Models, Animal; Frontal Lobe; Functional Laterality; Functional Neuroimaging; Glutamates; Glutamic Acid; Glutamine; Magnetic Resonance Spectroscopy; Male; Motor Activity; Oxidopamine; Parietal Lobe; Parkinson Disease, Secondary; Rats; Substantia Nigra; Time Factors | 2014 |
L-DOPA Reverses the Increased Free Amino Acids Tissue Levels Induced by Dopamine Depletion and Rises GABA and Tyrosine in the Striatum.
Topics: Amino Acids; Animals; Aspartic Acid; Corpus Striatum; Dopamine; Dyskinesia, Drug-Induced; Forelimb; gamma-Aminobutyric Acid; Glutamic Acid; Glycine; Levodopa; Mice; Oxidopamine; Rotarod Performance Test; Taurine; Tyrosine | 2016 |
L-Ornithine L-Aspartate Restores Mitochondrial Function and Modulates Intracellular Calcium Homeostasis in Parkinson's Disease Models.
Topics: Aspartic Acid; Calcium; Dipeptides; Dopaminergic Neurons; Fluorescent Dyes; Homeostasis; Humans; Mitochondria; Neuroblastoma; Ornithine; Oxidopamine; Parkinson Disease; Reactive Oxygen Species; Rotenone | 2022 |